Inverness Medical Innovations (IMA) Raises Bid for Biosite (BSTE) to $92.50

May 10, 2007 12:07 AM EDT

Inverness Medical Innovations (Amex: IMA) raises bid for Biosite (Nasdaq: BSTE) from $90 to $92.50 per share.

Biosite is currently in a merger agreement with Bechman Coulter (NYSE: BEC) to be acquired for $90 per share.

Inverness CEO Ron Zwanziger said they, "are confident that Biosite will respond favorably to our new offer and once again deem it a Superior Proposal."


Related Categories

Mergers and Acquisitions

Stocks Mentioned

BEC 65.45

+0.87 +1.35%
Volume: 119,640
Track BEC

BSTE 0.01

-92.48 -99.99%
Volume: 0
Track BSTE

IMA 41.94

+0.34 +0.82%
Volume: 63,316
Track IMA


Add Your Comment